Fritextsökning
Artiklar per år
Innehållstyper
-
Deras samarbete ska ge ett pulvervaccin mot influensa
De bägge Uppsalabolagen Abera Bioscience och Orexo inleder ett samarbete för att ta fram vaccin i pulverform mot bland annat influensa.
-
Nobla kreationer symboliserar årets Nobelpris
Elever från första årskursen på Beckmans Designhögskola har gestaltat 2024 års Nobelpris. Här ser du hur de naturvetenskapliga priserna gestaltas. Kan du gissa vilket som är vilket?
-
Large study on milk: Risky for women but not for men
The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while no such association was found in men, according to a new large Swedish study.
-
Moderna fälls efter 20 000-kronorserbjudande till barn
Moderna kritiseras i Storbritannien för ett felaktigt meddelande där barn erbjöds 1 500 pund, motsvarande över 20 000 kronor, för deltagande i en klinisk studie av bolagets covid-vaccin.
-
Sobi announces agreement with Enable Injections
Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.
-
What will be the next big hype after obesity? – An expert panel highlighted their top picks
What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major life science event in Lund.
-
Takeover bid is being completed – Japanese company acquires Calliditas
Japanese company Asahi Kasei completes the bid for Calliditas Therapeutics after reaching over 90 percent of the shareholding. Callidita's board has now decided to apply for delisting of the company´s share from Nasdaq Stockholm.
-
Artificial intelligence in radiology – “Risk prediction is very exciting”
A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiology at Lund University, radiology is a field that is well suited to the technology.
-
Boehringer Ingelheim köper amerikanskt bolag
Tyska Boehringer Ingelheim förvärvar det amerikanska bolaget Nerio Therapeutics.
-
CTR förvärvar Lundabolag inom topikala läkemedel
Bolagsgruppen Center for Translational Research, CTR, utökar sin portfölj genom förvärv av kontraktsforskningsbolaget Zelmic.
-
Redwood Pharma auktionerar ut tillgångar – förväntas vara klart i juli
Forskningsbolaget Redwood Pharma har bjudit in ett flertal oftalmologibolag i USA, Europa och Asien att delta i en auktionsprocess rörande bolagets tillgångar. Processen förväntas kunna avslutas under juli.
-
Bio Europe to Stockholm – ”The Swedish ecosystem is now taking the opportunity”
The international life science conference Bio Europe is coming to Sweden for the first time in November. The conference, whose program takes inspiration from ABBA songs, turns 30 this year. "There is great interest in Sweden and Swedish solutions globally," says Anna Redwood from Business Sweden.
-
Beslut väntas idag om Eli Lillys Alzheimerläkemedel
En oberoende panel till den amerikanska läkemedelsmyndigheten FDA kommer senare under måndagen att besluta om säkerheten och effektiviteten kring Eli Lillys läkemedelskandidat donanemab mot Alzheimers sjukdom.
-
Nobel Prize winner Torsten Wiesel turns 100: “Old men like me should use their experience to help the young”
In 1955, a young Torsten Wiesel jumped on a boat to the US and embarked on a fabulous career as a neuroscientist, crowned with a Nobel Prize for his work. Now 100 years old, he looks back on an intense life and his upbringing in Stockholm, Sweden, which shaped his desire to help the vulnerable in society.
-
Dansk-svenskt samarbete kring antibiotikaresistens i EU
Ett europeiskt referenslaboratorium för antibiotikaresistens ska etableras genom ett samarbete mellan Danmark och Sverige. Laboratoriet ska bidra med kunskap kring bland annat beredskap mot antibiotikaresistens.
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s competitiveness, the accessibility of health data and the integration of innovation in healthcare are some of the points that are essential to review.
-
”De egenskaper vi har som kvinnliga ledare är otroligt viktiga”
För ett år sedan startades nätverket Vilda, Nätverk för ledande kvinnor inom life science, med syftet att stärka kvinnligt ledarskap. På fredagen höll nätverket ett nationellt möte i Forskaren i Hagastaden där ett femtiotal kvinnor med ledande positioner inom sektorn möttes.
-
“What is important is to create an overview and understanding from different perspectives”
Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diagnostics of the Future event.
-
Acquisition of consulting company Key2Compliance
The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.
BREAKING